$15.43
4.6643.27%
Last update: Nov 4, 6:15 PM
Lyell Immunopharma Inc
LYELNASDAQ
The average analyst price target for Lyell Immunopharma is $31.63, 101.0% above the current price. Of 7 analysts, 6 rate it Buy and 1 Sell. Targets range from $10 to $45. The latest change came on Aug 6, 2026, when Stifel initiated coverage of Lyell Immunopharma with a Buy rating and a $36 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
